Clear 18°. Wind: E 3 mph.
Trending: Trump’s $300 million White House ballroom makeover faces day in court
HomeNewsNationalHealth ( Page 107)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Amazon investing over $1 billion to raise employee pay-and-lower health care costs

(Reuters) -Amazon.com is investing over $1 billion to raise pay-and-lower health care costs for U.S. fulfillment and transportation employees, the tech giant said on Wednesday.(Reporting by Arsheeya Bajwa in Bengaluru; Editing by Shreya Biswas) Brought to you by www.srnnews.com
by

J&J’s experimental psoriasis drug shows promise against Bristol’s treatment

(Reuters) -Johnson & Johnson said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb’s Sotyktu in two late-stage head-to-head trials. J&J said its icotrokinra met both main and secondary goals and showed superiority to Bristol’s Sotyktu at multiple ...
by

Lilly says its experimental GLP-1 pill better than Novo’s Rybelsus in diabetes study

(Reuters) -Eli Lilly on Wednesday said its experimental pill led to more weight loss and better control of blood sugar in patients with diabetes than oral semaglutide, the active ingredient in Danish rival Novo Nordisk’s diabetes and weight-loss medicines. The late-stage head-to-head trial compared two ...
by

Regeneron’s bone disorder treatment succeeds in late-stage trial

(Reuters) -Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder that affects bone tissue has met the main goal of a late-stage trial. The company said its drug, garetosmab, was highly efficacious in reducing abnormal bone growth in patients with fibrodysplasia ...
by

Health Rounds: Laser surgery safe for nearsighted teens, study shows

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid (Reuters) -Laser surgery for nearsightedness is as safe and effective in older teenagers as it is in adults, researchers reported on Tuesday in ...
by

Eli Lilly cautious on using FDA fast-track voucher for weight-loss pill

VIENNA (Reuters) – Eli Lilly’s international president said on Wednesday it was too early to assume the company would use the U.S. Food and Drug Administration’s new fast-track review process for its experimental weight-loss pill orforglipron. ...
https://www.osfhealthcare.org/c/only-at-osf-w
by

AstraZeneca’s asthma drug fails ‘smoker’s lung’ study

(Reuters) – AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic obstructive pulmonary disease (COPD) in a late-stage study, in a setback to efforts to help tackle a severe lung ...
by

Swiss Re says GLP-1 drugs could reduce US mortality by up to 6.4%

FRANKFURT (Reuters) -Reinsurance company Swiss Re said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual rate of death by up to 6.4% in the United States by 2045. The GLP-1 drug class, which include Novo Nordisk’s Wegovy ...
by

Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy

By Maggie Fick and Mrinalika Roy VIENNA (Reuters) -Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects to replicate its U.S. dominance globally, the company’s international president told Reuters on Wednesday. ...
by

Novo Nordisk’s Alzheimer’s trial a ‘lottery ticket’, senior executive says

COPENHAGEN (Reuters) -Novo Nordisk is prepared for a full-fledged launch of oral semaglutide in the United States in 2026, the group’s head of product and portfolio strategy told Reuters on Wednesday.(Reporting by Stine Jacobsen, editing by Terje Solsvik) Brought to you by www.srnnews.com
by

GSK plans $30 billion US investment as pharma tariff threat looms

By Maggie Fick (Reuters) -GSK said on Wednesday it plans to invest $30 billion in research and development and supply chain infrastructure in the United States over the next five years, after U.S. President Donald Trump arrived in Britain for an unprecedented second state visit ...
by

Lilly trial shows weight loss with experimental pill flattens over time

By Deena Beasley (Reuters) -Eli Lilly’s experimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for most patients in the 72-week trial, according to full study results presented at a medical meeting on Tuesday. Lilly had announced in August ...
First Previous103104105106107108109110111Next Last